Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adherence to Hormone Therapy”

52 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 52 results

Not applicableStudy completedNCT04054557
What this trial is testing

Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence

Who this might be right for
Stage 0 Breast Cancer AJCC v6 and v7Stage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7+8 more
Thomas Jefferson University 305
Not applicableActive Not RecruitingNCT04086875
What this trial is testing

A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+18 more
Thomas Jefferson University 332
Not applicableStudy completedNCT03849573
What this trial is testing

A Web-Based Tool to Improve Breast Cancer Survivorship

Who this might be right for
Breast CancerHormone Dependent NeoplasmsAdherence to Hormone Therapy
Northwestern University 84
Not applicableStudy completedNCT03592771
What this trial is testing

THRIVE Breast Cancer App Study

Who this might be right for
Breast Neoplasm Female
Emory University 304
Not applicableStudy completedNCT01400997
What this trial is testing

Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Czech Republic

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 206
Not applicableStudy completedNCT02400060
What this trial is testing

Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer

Who this might be right for
Stage IA Breast CancerStage IB Breast CancerStage IIA Breast Cancer+5 more
Ohio State University Comprehensive Cancer Center 39
Not applicableStudy completedNCT06246084
What this trial is testing

INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy

Who this might be right for
Breast CancerBreast Cancer FemaleBreast Carcinoma
Dana-Farber Cancer Institute 76
Not applicableStudy completedNCT03447886
What this trial is testing

Understanding Barriers to Initiation and Adherence to Endocrine Therapy in Young Breast Cancer Survivors of Diverse Backgrounds

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 17
Not applicableStudy completedNCT00878930
What this trial is testing

Parameters of Acceptability, Compliance and Efficacy of Fulvestrant in Post-menopausal Patients With Advance Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 500
Not applicableStudy completedNCT01582334
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Argentina

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 68
Not applicableStudy completedNCT01376921
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Spain

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 300
Not applicableEnded earlyNCT05488145
What this trial is testing

A Feasibility Trial of a Web Based App Intervention in Hormone Positive Breast Cancer Patients to Improve Adherence to Endocrine Therapy

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8HER2-Negative Breast Carcinoma+1 more
Emory University 21
Not applicableStudy completedNCT01291394
What this trial is testing

To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in France

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 223
Not applicableNot Yet RecruitingNCT06865755
What this trial is testing

Collaborative Research: Multiscale Modeling and Intervention for Improving Long-Term Medication

Who this might be right for
Breast Cancer SurvivorBreast Cancer Early Stage Breast Cancer (Stage 1-3)
San Diego State University 15
Not applicableStudy completedNCT01438528
What this trial is testing

Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ Electromechanical Device for Growth Hormone Treatment

Who this might be right for
Growth Disorders
Merck KGaA, Darmstadt, Germany 75
Not applicableNot Yet RecruitingNCT07443774
What this trial is testing

Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence.

Who this might be right for
ER+ Breast CancerBreast CancerEarly Breast Cancer+3 more
University Hospital, Grenoble 81
Not applicableLooking for participantsNCT06650423
What this trial is testing

Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer

Who this might be right for
Early Breast CancerHormone Receptor Positive TumorHER2-negative Breast Cancer
Institute of Oncology Ljubljana 319
Not applicableLooking for participantsNCT05887102
What this trial is testing

Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors

Who this might be right for
Breast NeoplasmsBreast Cancer
CHU de Quebec-Universite Laval 66
Not applicableUnknownNCT04176809
What this trial is testing

Health-Related Quality of Life Coupled With Therapeutic Information on Compliance to Endocrine Therapy in Breast Cancer

Who this might be right for
Breast Cancer
Centre Georges Francois Leclerc 342
Not applicableEnded earlyNCT00555867
What this trial is testing

Patient's Anastrozole Compliance to Therapy Programme

Who this might be right for
Breast Cancer
AstraZeneca 4,923
Load More Results